I used to hear about it all the time: “There’s nothing useful from pot. Cannabis is just the Devil’s Lettuce!” If you’re over 50 years of age, you probably heard this or something quite similar. But science, once constrained by politics, does tend to help prove old Wives’ Tale or commonly accepted propositions from the pulpit are not always correct. If they were correct, Why was CBD Approved for Treating Neurological Conditions?
It is important to note that Carolina Hemp Hut and multitudes of other retail firms were established because of the “decriminalization” of the compound Cannabidiol.
What is Cannabidiol used to treat?
Cannabidiol is the main compound found within Epidiolex. Epidiolex is an oral solution containing cannabidiol (CBD) that was approved by the US Food and Drug Administration (FDA) for the treatment of two rare and severe forms of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome. The approval of Epidiolex was based on the results of several clinical trials that demonstrated its efficacy in reducing the frequency and severity of seizures in patients with these conditions.
In the trials, patients with Lennox-Gastaut syndrome and Dravet syndrome who were treated with Epidiolex experienced significant reductions in the frequency of seizures compared to those who received a placebo. These results were observed across multiple studies and were consistent over time, providing evidence of the drug’s efficacy.
Is CBD Considered safe?
The safety profile of Epidiolex was well-established in these trials, with the most common side effects being drowsiness, fatigue, and decreased appetite.
Overall, the results of these clinical trials provided strong evidence to support the approval of Epidiolex for the treatment of seizures and other neurological conditions, and helped to establish CBD as a potential therapeutic agent for these conditions.
GW Pharmaceuticals conducted several clinical trials to evaluate the efficacy and safety of CBD in patients with epilepsy, and the results of these trials provided strong evidence to support the approval of Epidiolex for the treatment of seizures and other neurological conditions.
What company decided to use Hemp to treat Seizures?
Epidiolex was developed by GW Pharmaceuticals, a British biopharmaceutical company that specializes in the development of plant-derived cannabinoid medicines.
GW Pharmaceuticals chose CBD as the main compound in Epidiolex because of its potential therapeutic benefits for patients with epilepsy and other neurological conditions. CBD is one of the many compounds found in the cannabis plant, and is believed to have a wide range of therapeutic effects, including anticonvulsant, anxiolytic, and antipsychotic properties.
In early preclinical studies, CBD was shown to have a potent anticonvulsant effect and was effective in reducing seizures in animal models of epilepsy. These results encouraged further research into the potential use of CBD for treating epilepsy and other neurological condition
GW Pharmaceuticals submitted its New Drug Application (NDA) for Epidiolex to the US Food and Drug Administration (FDA) in December 2016, and the FDA approved the drug in June 2018.
The US Farm Bill 2018, which legalized hemp, was signed into law on December 20, 2018. So, the approval of Epidiolex by the FDA came several months before the legalization of hemp in the United States.
It’s important to note that while hemp and marijuana both come from the cannabis plant, hemp contains only trace amounts of THC (tetrahydrocannabinol), the psychoactive compound found in weed or marijuana, while marijuana can contain significant levels of THC. In contrast, Epidiolex is a pharmaceutical drug that contains pure CBD (cannabidiol) and is used to treat specific medical conditions. Simply stated: CBD was Approved for Treating Neurological Conditions associated with seizures.
Now that Hemp is legal, Will CBD remain legal too?
The legalization of hemp under the US Farm Bill 2018 has had a significant impact on the cannabis industry and has paved the way for the development of new products and therapies made from hemp-derived compounds, including CBD. However, it is still important to note that the regulation and approval of drugs, such as Epidiolex, falls under the jurisdiction of the FDA and is subject to different regulations and standards compared to hemp-derived products.
David P. Carter
Operations/Marketing
David is a Cancer fighter and advocate for healthy living. He’s a continued survivor of significant health challenges and credits cannabis, cuisine (better nutrition), and positive thinking with his continued health successes David is an avid researcher of all things hemp, cannabis, botanical, and natural health. He’s written numerous guest articles and continues to provide articles for Carolina Hemp Hut, NYC CBD Source and other retail and educational web sites. David can be reached for public-speaking events and Zoom presentations via the Carolina Hemp Hut “contact” page or through the Ziglar Legacy Training portal.